The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 drugs Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- How One Man Conquered the World’s Toughest Peaks — and Built a Brand Every Founder Should Study
- Fox Weather Gets a Brand Refresh Ahead of Fourth Anniversary
- 5 style icons from Indian television whose wardrobe you could steal from even now | Fashion News
- Trump’s plan to penalize states using cashless bail is unconstitutional and unnecessary, critics say
- Want to Sell More? Make Your Team Less Competitive, Not More
- Coca-Cola Claimed Christmas. Now Fanta Wants Halloween.
- An internal medicine doctor explains why you might feel sleepy on the couch but not in bed | Lifestyle News
- Is Costco Open on Labor Day? What’s Closed on Monday?
Thursday, August 28
Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’
